Jeffrey H. Murray

Array ( [id] => 8028377 [patent_doc_number] => 08143272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => '3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/636269 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28436 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143272.pdf [firstpage_image] =>[orig_patent_app_number] => 12636269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651840 [patent_doc_number] => 20110301109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/139156 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42635 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301109.pdf [firstpage_image] =>[orig_patent_app_number] => 13139156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446219 [patent_doc_number] => 20100144758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'AZAINDOLE P2X3 AND P2X2/3 MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/634031 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21079 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144758.pdf [firstpage_image] =>[orig_patent_app_number] => 12634031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127230 [patent_doc_number] => 08575179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Dihydropyrazolopyrimidinone derivatives' [patent_app_type] => utility [patent_app_number] => 13/133671 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37402 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831394 [patent_doc_number] => 08859564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1' [patent_app_type] => utility [patent_app_number] => 13/133096 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15847 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221815 [patent_doc_number] => 20120136013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/133147 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27611 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413673 [patent_doc_number] => 08697710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones' [patent_app_type] => utility [patent_app_number] => 13/132955 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22437 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696085 [patent_doc_number] => 20110230505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'QUINAZOLINE INHIBITORS OF BACE 1 AND METHODS OF USING' [patent_app_type] => utility [patent_app_number] => 13/130508 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10787 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230505.pdf [firstpage_image] =>[orig_patent_app_number] => 13130508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099683 [patent_doc_number] => 08563561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => '3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo[4,3-b]pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 13/140451 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16110 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307218 [patent_doc_number] => 20100069408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition' [patent_app_type] => utility [patent_app_number] => 12/591395 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12702 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069408.pdf [firstpage_image] =>[orig_patent_app_number] => 12591395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082135 [patent_doc_number] => 08148387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'AKT and P70 S6 kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/611139 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34826 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148387.pdf [firstpage_image] =>[orig_patent_app_number] => 12611139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594846 [patent_doc_number] => 20100048533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'LESTAURTINIB CRYSTALLINE FORM 1, CRYSTALLINE LESTAURIMIB ANHYDRATE AND AMORPHOUS LESTAURIMIB' [patent_app_type] => utility [patent_app_number] => 12/607799 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7840 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048533.pdf [firstpage_image] =>[orig_patent_app_number] => 12607799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167429 [patent_doc_number] => 20110195948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/125263 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30409 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195948.pdf [firstpage_image] =>[orig_patent_app_number] => 13125263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497939 [patent_doc_number] => 20100094010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CHEMICAL PROCESS' [patent_app_type] => utility [patent_app_number] => 12/580704 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20100094010.pdf [firstpage_image] =>[orig_patent_app_number] => 12580704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214353 [patent_doc_number] => 08193188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Methods of using pyridodihydropyrazinones' [patent_app_type] => utility [patent_app_number] => 12/578737 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193188.pdf [firstpage_image] =>[orig_patent_app_number] => 12578737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501750 [patent_doc_number] => 20110263607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/124104 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 72500 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263607.pdf [firstpage_image] =>[orig_patent_app_number] => 13124104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712408 [patent_doc_number] => 08093255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Imidazo[1,2-A]pyrimidines as orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/576331 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8912 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093255.pdf [firstpage_image] =>[orig_patent_app_number] => 12576331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401253 [patent_doc_number] => 20100179123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'THIENOPYRIMIDINES USEFUL AS AURORA KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/575560 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 46374 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179123.pdf [firstpage_image] =>[orig_patent_app_number] => 12575560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317499 [patent_doc_number] => 08232279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Pyrazolopyrimidine derivatives having biological activity on serotonin receptor 5-HT2c' [patent_app_type] => utility [patent_app_number] => 12/575235 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2783 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12575235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254697 [patent_doc_number] => 08618114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof' [patent_app_type] => utility [patent_app_number] => 13/122152 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25350 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122152 [rel_patent_id] =>[rel_patent_doc_number] =>)